Growth through expansion Reach Separations has recently invested in UK and France laboratories to meet growing demand, signaling capacity for increased testing and service volume. This presents an opportunity to upsell larger project scopes, retainer-based analysis, and expanded purification services with new geographic coverage.

Chiral separation leadership Specialization in chiral separation for small molecules positions Reach as a cost-effective, expert partner for pharmaceutical, agrochemical, and fine chemical companies seeking scalable enantioselective analysis and purification capabilities.

Strategic partnerships Recent collaborations with CatSci and SFE Process indicate an openness to integrated solutions and co-developed workflows. There is potential to propose joint development programs, shared IP, and bundled services for discovery and early development stages.

Technology-forward services Adoption of latest HPLC and SFC technologies suggests capacity to handle complex separations and high-throughput demands. This can be leveraged to target clients with stringent purity requirements, scale-up needs, or late-stage purification challenges.

apprenticeship and talent growth Commitment to apprenticeships and skilled staff indicates a stable, invest-in-people approach. This can be highlighted to prospective customers as reliability in project execution, training capabilities for client teams, and a strong compliance-conscious partner ready for fast-moving programs.